Sudarshan Pharma Eyes Global Growth with Proposed 9.5 Percent Stake in US-Based MedTherapy Biotechnology
Sudarshan Pharma Eyes Global Growth with Proposed 9.5% Stake in US-Based MedTherapy Biotechnology Mumbai (Maharashtra) [India], September 7: Sudarshan Pharma Industries Limited is looking to accelerate its global expansion and diversify into advanced oncology with a proposed acquisition of a 9.50% equity stake in US-based MedTherapy Biotechnology Inc. The strategic investment, approved by the company’s […]
Continue Reading